++
The main diseases facing the international traveller are traveller’s diarrhoea (relatively mild) and malaria, esp. CRFM
Infections transmitted by mosquitoes include malaria, yellow fever, Rift Valley fever, Japanese encephalitis, Zika virus and dengue fever; preventing their bites is excellent prevention
STIs, incl. HIV, of concern in certain areas
Prevention of disease is a key role for the GP (Table T6).
++
++
++
++
++
++
++
++
Treatment of breakthrough malaria during travel (where medical care unavailable):
++
Mefloquine 500 mg (2 tabs) statim; repeat after 6–8 h or artemether/lumefantrine (Riamet) 4 tabs at 0, 8, 24, 36, 48, 60 h
++
Summary of recommendations
PFM area: mefloquine 250 mg/wk or doxycycline 100 mg/d or atovaquone + proguanil
Multidrug-resistant area: Malarone for prophylaxis
Standby treatment: artemether/lumefantrine or Malarone
PFM = Plasmodium falciparum malaria
+++
FEVER IN THE RETURNED TRAVELLER
++
Probability diagnosis: malaria, respiratory tract infection incl. bacterial pneumonia, gastroenteritis, dengue fever, Hepatitis A.
++
Serious disorders: as above, TB, typhoid, encephalitis, meningococcal meningitis, melioidosis, amoebiasis (liver abscess), all haemorrhagic fevers, schistosomiasis, African trypanosomiasis.
++
Investigations (if no obvious cause): FBE (?eosinophils), ESR/CRP, thick and thin blood films, blood culture, LFTs, urine M&C, stool M&C, new malaria tests, CXR.
+++
Traveller’s diarrhoea
++
The illness is usually mild and lasts only 2–3 d. Unusual to last longer than 5 d. Mainly caused by an E. coli strain.
++
++
++
++
++